Full text of CAMBRIDGE INVESTMENT RESEARCH, INC.'s X-17A-5 filed 2022-02-25 (period 2021-12-31). Broker-dealer annual report from SEC EDGAR — readable, searchable, and available as markdown for AI agents.
{0}------------------------------------------------ # **Cambridge Investment Research, Inc.** Financial Report December 31, 2021 This report is deemed PUBLIC in accordance with Rule 17a-5(e)(3) under the Securities Exchange Act of 1934 and Regulation 1.10(g) under the Commodity Exchange Act. {1}------------------------------------------------ #### **Contents** | Report of Independent Registered Public Accounting Firm | | | |---------------------------------------------------------|--------|--| | | | | | Statement of Financial Condition | 2 | | | Notes to Financial Statement | 3 – 10 | | {2}------------------------------------------------ {3}------------------------------------------------ #### **Cambridge Investment Research, Inc.** # **Statement of Financial Condition December 31, 2021** #### **Assets** | Cash and cash equivalents | \lt;br>9,377,416 | |------------------------------------------------------------------------|------------------| | Receivables: | | | Clearing brokers | 12,210,450 | | Commissions | 57,832,526 | | Loans to registered and investment advisor representatives, | | | net of allowance for estimated credit losses of 2021 \$456,141 | 41,903,002 | | Other | 4,514,544 | | Deposits with clearing brokers | 360,000 | | Securities owned, at fair value | 9,358,329 | | Intangible assets - registered representative practice related assets, | | | net of accumulated amortization of 2021 \$2,424,045 | 696,683 | | Officer life insurance | 8,324,867 | | Deferred income taxes | 1,418,000 | | Other assets | 4,726,570 | | Total assets | \$ 150,722,387 | | Liabilities and Shareholder's Equity | | | Liabilities: | | | Commissions payable | \lt;br>60,206,352 | | Accounts payable | 1,674,612 | | Accrued expenses | 50,000 | | Due to clearing broker | 1,340,046 | | Securities sold, not yet purchased, at fair value | 93,475 | | Due to affiliates | 6,927,211 | | Total liabilities | 70,291,696 | | Commitments and Contingencies (Note 6) | | | Shareholder's Equity: | | | Common stock, \$.01 par value; 750,000 shares authorized; | | | 10,000 shares issued and outstanding | 100 | | Additional paid-in capital | 831,028 | | Retained earnings | 79,599,563 | | Total shareholder's equity | 80,430,691 | | Total liabilities and shareholder's equity | \$ 150,722,387 | | | | See Notes to Financial Statement. {4}------------------------------------------------ # **Note 1. Summary of Significant Accounting Policies** Organization and business: Cambridge Investment Research, In…Read the full text as markdown